D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
4
Petroleo Brasileiro SA Petrobras
PBR
5
Ecopetrol
EC
US Stock MarketDetailed Quotes
VIRX Viracta Therapeutics
- 0.030
- -0.025-45.09%
15min DelayClose Mar 10 16:00 ET
1.20MMarket Cap-0.03P/E (TTM)
0.050High0.026Low385.13KVolume0.033Open0.055Pre Close14.82KTurnover1.23%Turnover RatioLossP/E (Static)39.74MShares1.31052wk High-0.18P/B946.06KFloat Cap0.00852wk Low--Dividend TTM31.33MShs Float9324.000Historical High--Div YieldTTM44.55%Amplitude0.008Historical Low0.038Avg Price1Lot Size
About Viracta Therapeutics Company
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.
Company Profile
SymbolVIRX
Company NameViracta Therapeutics
Listing DateSep 27, 2005
Issue Price7.00
Founded1998
CEOMr. Mark Andrew Rothera
MarketPink Market
Employees40
Fiscal Year Ends12-31
Address2533 South Coast Highway 101,Suite 210
CityCardiff
ProvinceCalifornia
CountryUnited States of America
Zip Code92007
Phone1-858-400-8470
Websitehttp://www.viracta.com
Company Executives
- Name
- Position
- Salary
- Mark Andrew Rothera
- Chief Executive Officer, President and Director
- 1.46M
- Dr. Darrel P. Cohen, M.D.,PhD
- Chief Medical Officer
- 756.73K
- Michael E. Faerm
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Melody Burcar
- Senior Vice President, Finance
- --
- Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
- Chairman of the Board
- 210.27K
- Dr. Ivor Royston, M.D.
- Director
- 90.76K
- Dr. Flavia Borellini, PhD
- Independent Director
- 92.36K
- Thomas E. Darcy
- Independent Director
- 113.26K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings